Krisztina Nemenyi

Dr. Nemenyi joined Cyteir in May 2022 and is an experienced R&D regulatory leader with 20 years of experience across diverse organizations, regions, and responsibilities. She joins Cyteir from Takeda Pharmaceuticals, where she most recently served as VP, Global Program Lead for Oncology, ensuring successful registration of mobocertinib for the treatment of EGFR Exon 20 non-small cell lung cancer in the United States and United Kingdom. During her seven-year tenure at Takeda, she served as VP, Global Regulatory Affairs, Oncology, responsible for global regulatory affairs for oncology, as well as Vice President of Global Regulatory Affairs, Emerging Markets and Marketed Products. Prior to joining Takeda, Ms. Nemenyi spent eight years at Bristol Myers Squibb, first as Director, Oncology, leading a broad spectrum of the oncology portfolio, then as Head of Asia-Pacific, Global Regulatory Affairs. She also held regulatory positions at Baxter and Bayer Pharmaceuticals.

Ms. Nemenyi received her MS in chemical engineering, biochemistry from the Technical University of Budapest, Hungary, and her Ph.D. in chemical engineering and environmental chemistry from the Technical University of Vienna, Austria.